迈普医学
(301033)
| 流通市值：30.21亿 | | | 总市值：35.94亿 |
| 流通股本：5638.68万 | | | 总股本：6708.27万 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 97,987,547.7 | 107,238,882.98 | 74,017,230.33 | 75,952,713.87 |
| 交易性金融资产 | 184,572,967.4 | 193,998,906.56 | 231,812,485.83 | 179,357,093.19 |
| 应收票据及应收账款 | 27,366,955.45 | 19,727,233.17 | 25,027,134.39 | 16,366,382.17 |
| 应收账款 | 27,366,955.45 | 19,727,233.17 | 25,027,134.39 | 16,366,382.17 |
| 预付款项 | 6,147,240.61 | 7,473,700.29 | 4,899,054.78 | 7,162,338.79 |
| 其他应收款合计 | 1,477,949.01 | 1,618,652.21 | 1,108,003.26 | 1,573,161.09 |
| 存货 | 43,036,603.99 | 45,443,124.18 | 37,064,500.38 | 41,399,550.57 |
| 其他流动资产 | 779,198.02 | 2,750,550.47 | 1,265,774.35 | 371,547.07 |
| 流动资产合计 | 361,368,462.18 | 378,251,049.86 | 375,194,183.32 | 322,182,786.75 |
| 非流动资产: | | | | |
| 其他权益工具投资 | 7,259,136.1 | 2,284,798.71 | 2,364,417.94 | 2,393,689.34 |
| 其他非流动金融资产 | 58,000,000 | 58,000,000 | 58,000,000 | 58,000,000 |
| 投资性房地产 | 10,905,375.72 | 10,976,612.28 | 11,047,848.84 | 11,116,468.27 |
| 固定资产 | 294,775,793.59 | 294,953,357.88 | 299,378,337.74 | 302,127,885.01 |
| 在建工程 | 4,132,420.55 | 985,321.1 | 0 | 476,608.06 |
| 使用权资产 | 8,943,460.1 | 9,174,756.47 | - | 124,978.91 |
| 无形资产 | 64,220,741.91 | 66,079,307.85 | 68,094,289.73 | 69,701,584.13 |
| 开发支出 | 36,199,839.88 | 34,872,919.06 | 32,889,491.56 | 23,189,214.18 |
| 长期待摊费用 | 938,269.06 | 927,838.77 | 1,025,604.21 | 1,123,369.65 |
| 递延所得税资产 | 8,777,715.21 | 9,389,065.62 | 9,827,815.82 | 13,848,103.56 |
| 其他非流动资产 | 45,781,525.07 | 41,932,925.2 | 37,614,574.2 | 40,292,741.92 |
| 非流动资产合计 | 539,934,277.19 | 529,576,902.94 | 520,242,380.04 | 522,394,643.03 |
| 资产总计 | 901,302,739.37 | 907,827,952.8 | 895,436,563.36 | 844,577,429.78 |
| 流动负债: | | | | |
| 衍生金融负债 | 78,527.03 | 64,103.77 | 153,298.98 | 37,276.25 |
| 应付票据及应付账款 | 12,863,995.49 | 12,849,672.9 | 16,420,924.93 | 7,157,805.32 |
| 应付账款 | 12,863,995.49 | 12,849,672.9 | 16,420,924.93 | 7,157,805.32 |
| 预收款项 | 1,044,777.7 | 1,851,692.09 | 1,030,081.02 | 2,418,406.21 |
| 合同负债 | 1,283,077.36 | 2,124,603.11 | 1,184,552.54 | 920,280.35 |
| 应付职工薪酬 | 7,727,606.11 | 6,888,392.95 | 17,344,484.04 | 7,349,252.43 |
| 应交税费 | 11,237,023.81 | 6,903,197.89 | 10,797,815.03 | 13,506,044.55 |
| 其他应付款合计 | 3,259,718.04 | 3,329,037.64 | 4,607,066.87 | 13,949,178.29 |
| 一年内到期的非流动负债 | 633,617.83 | 439,778.94 | - | 150,868.5 |
| 其他流动负债 | 39,149.27 | 198,998.41 | 28,979.64 | 25,676.76 |
| 流动负债合计 | 38,167,492.64 | 34,649,477.7 | 51,567,203.05 | 45,514,788.66 |
| 非流动负债: | | | | |
| 租赁负债 | 8,699,427.51 | 8,812,076.32 | - | - |
| 递延收益 | 42,679,393.25 | 44,112,580.66 | 45,512,734.88 | 47,430,413.21 |
| 递延所得税负债 | 270,047.64 | 290,381.79 | 297,474.16 | 261,464.02 |
| 非流动负债合计 | 51,648,868.4 | 53,215,038.77 | 45,810,209.04 | 47,691,877.23 |
| 负债合计 | 89,816,361.04 | 87,864,516.47 | 97,377,412.09 | 93,206,665.89 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 67,049,620 | 67,049,620 | 67,049,620 | 66,611,929 |
| 资本公积 | 488,391,931 | 485,947,054.33 | 484,691,135.89 | 479,305,124.23 |
| 减:库存股 | 7,894,238.37 | 7,894,238.37 | 7,894,238.37 | 11,509,159.15 |
| 其他综合收益 | 1,170,008.96 | 1,191,609.18 | 1,258,624.68 | 1,283,262.42 |
| 盈余公积 | 32,712,914.9 | 32,712,914.9 | 32,712,914.9 | 21,322,714.94 |
| 未分配利润 | 230,056,141.84 | 240,956,476.29 | 220,241,094.17 | 194,356,892.45 |
| 归属于母公司股东权益合计 | 811,486,378.33 | 819,963,436.33 | 798,059,151.27 | 751,370,763.89 |
| 股东权益合计 | 811,486,378.33 | 819,963,436.33 | 798,059,151.27 | 751,370,763.89 |
| 负债和股东权益合计 | 901,302,739.37 | 907,827,952.8 | 895,436,563.36 | 844,577,429.78 |
| 公告日期 | 2026-08-21 | 2026-04-28 | 2026-04-28 | 2025-10-24 |
| 审计意见(境内) | | | 标准无保留意见 | |